Phase 3 Randomized Clinical Trial Evaluating the Safety of Reproxalap in Patients With Dry Eye Disease.
Saved in:
| Title: | Phase 3 Randomized Clinical Trial Evaluating the Safety of Reproxalap in Patients With Dry Eye Disease. |
|---|---|
| Authors: | Radcliffe NM; Mt Sinai School of Medicine, New York, NY, USA., Sheppard J; Virginia Eye Consultants, Norfolk, VA, USA., Simmons B; Vision Institute, Colorado Springs, CO, USA., Owen D; AbbVie Inc., North Chicago, IL, USA., Nguyen A; AbbVie Inc., North Chicago, IL, USA., Cavanagh B; Aldeyra Therapeutics, Inc, 131 Hartwell Avenue, Suite 320, Lexington, MA, 02421, USA., Brady TC; Aldeyra Therapeutics, Inc, 131 Hartwell Avenue, Suite 320, Lexington, MA, 02421, USA. tbrady@aldeyra.com. |
| Source: | Ophthalmology and therapy [Ophthalmol Ther] 2026 May; Vol. 15 (5), pp. 1807-1821. Date of Electronic Publication: 2026 Apr 11. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Healthcare Country of Publication: England NLM ID: 101634502 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8245 (Print) NLM ISO Abbreviation: Ophthalmol Ther Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41964731 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Phase 3 Randomized Clinical Trial Evaluating the Safety of Reproxalap in Patients With Dry Eye Disease. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Radcliffe+NM%22">Radcliffe NM</searchLink>; Mt Sinai School of Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Sheppard+J%22">Sheppard J</searchLink>; Virginia Eye Consultants, Norfolk, VA, USA.<br /><searchLink fieldCode="AU" term="%22Simmons+B%22">Simmons B</searchLink>; Vision Institute, Colorado Springs, CO, USA.<br /><searchLink fieldCode="AU" term="%22Owen+D%22">Owen D</searchLink>; AbbVie Inc., North Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Nguyen+A%22">Nguyen A</searchLink>; AbbVie Inc., North Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Cavanagh+B%22">Cavanagh B</searchLink>; Aldeyra Therapeutics, Inc, 131 Hartwell Avenue, Suite 320, Lexington, MA, 02421, USA.<br /><searchLink fieldCode="AU" term="%22Brady+TC%22">Brady TC</searchLink>; Aldeyra Therapeutics, Inc, 131 Hartwell Avenue, Suite 320, Lexington, MA, 02421, USA. tbrady@aldeyra.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101634502%22">Ophthalmology and therapy</searchLink> [Ophthalmol Ther] 2026 May; Vol. 15 (5), pp. 1807-1821. <i>Date of Electronic Publication: </i>2026 Apr 11. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Healthcare%22">Springer Healthcare </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101634502 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2193-8245 (Print) <i>NLM ISO Abbreviation: </i>Ophthalmol Ther <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41964731 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40123-026-01379-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1807 Titles: – TitleFull: Phase 3 Randomized Clinical Trial Evaluating the Safety of Reproxalap in Patients With Dry Eye Disease. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Radcliffe NM – PersonEntity: Name: NameFull: Sheppard J – PersonEntity: Name: NameFull: Simmons B – PersonEntity: Name: NameFull: Owen D – PersonEntity: Name: NameFull: Nguyen A – PersonEntity: Name: NameFull: Cavanagh B – PersonEntity: Name: NameFull: Brady TC IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May Type: published Y: 2026 Identifiers: – Type: issn-print Value: 2193-8245 Numbering: – Type: volume Value: 15 – Type: issue Value: 5 Titles: – TitleFull: Ophthalmology and therapy Type: main |
| ResultId | 1 |